Despite their early protective immunity, CD28-sufficient mice showed at the late phase of infection a persistent presence of Treg cells, impaired T cell responses, elevated production of anti-inflammatory cytokines and higher mortality rates when compared with CD28−/- mice [103]. This evidence concerns the gene CD28 and infection.